The South Florida Water Management District's monthly competition is winding down for 2025. Who took the top prize in November?

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

As the U.S. Treasury phases out the use of the penny, it’s creating a host of new challenges for businesses and consumers that could cost all of us a good chunk of change. That’s because eliminating ...

Measles outbreaks are spreading across the U.S., and the nation is likely to lose its status as a country where the disease is eliminated, something that infectious disease specialists say is directly ...

With just five weeks remaining in the regular season, all eyes in and around the NFL are on the playoff picture, and with good reason. The picture is as close and as muddied as it has ever been in ...

An elimination period is the time from injury to benefit payments in insurance. It is also known as a "waiting" or "qualifying" period. During the elimination period, policyholders must cover their ...